Cancers
14
2
2
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
90.9%
+4.4% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (14)
A Phase 1 Study of NM6603 in Advanced Solid Tumors
Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)
The International Polycap Study 3 (TIPS-3)
Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test
Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project
The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
Swedish Mammography Cohort
Cohort of Swedish Men
Animal Assisted Therapy in a Pediatric Setting
Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC